A Mab A Case Study In Bioprocess Development →

: Common examples include aggregation, glycosylation profiles, and host cell proteins (HCP). 2. Characterize the Process

Humanized IgG1 mAb targeting a cancer antigen. Indication: Solid tumors. Target Dose: 500 mg per patient, every 3 weeks. Annual Demand: 50 kg (clinical → early commercial). Critical Quality Attributes (CQAs):

The upstream process for Mab-X begins with a Chinese Hamster Ovary (CHO) cell line engineered to secrete the antibody. The case study focuses on three key challenges:

Are you working in upstream or downstream process development? What are the biggest bottlenecks you are facing in your current projects? Let us know in the comments.

A detailed breakdown of a (like Protein A chromatography).